5:54 PM
 | 
Nov 08, 2013
 |  BC Extra  |  Company News

EC approves first-line use of Bristol-Myers' Yervoy

Bristol-Myers Squibb Co. (NYSE:BMY) said the European Commission approved an application to expand the label of Yervoy ipilimumab...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >